Mabeya, Hillary
Menon, Sonia
Weyers, Steven
Naanyu, Violet
Mwaliko, Emily
Kirop, Elijah
Orango, Omenge
Vermandere, Heleen
Vanden Broeck, Davy
Funding for this research was provided by:
Merck (3000546647)
VRIL University of Ghent/ Moi University partnership
Article History
Received: 6 March 2017
Accepted: 17 April 2018
First Online: 11 May 2018
Ethics approval and consent to participate
: The HPV vaccination program was rolled out from May 2012 till March 2013 in Eldoret, Kenya. With support from the GARDASIL Access Program (GAP) through donation of Gardasil from Merck. Moi Referral and Teaching Hospital was able to vaccinate 3000 girls against cervical cancer. The vaccines were given for free in the hospital on Wednesdays and Saturdays. Promotion took place in ten randomly selected schools as to avoid over-demand in the community. Through this, 4000 eligible girls, i.e. girls from class 4 to 8 (9–14 years old), were targeted. Health care providers went to the schools to inform the teachers who were then asked to promote the vaccine among the students and their parents. The parents gave a written consent before each girl was vaccinated.Written consent to the survey was obtained from all parents/guardians. Information collected was kept confidential by using numbers and codes. Ethical approval was obtained from the Ethics Committee of the Moi Teaching and Referral Hospital/Moi University School of Medicine (IREC). FAN: IREC 0001609.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.